SCHEMBL16410818

SCHEMBL16410818

Fc1cccc(CNNC2=Nc3ccccc3NC23CCSCC3)c1

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ SSTR3 P32745 1/20 0.32
▸ KDM1A O60341 2/20 0.32
▸ MAOA P21397 1/20 0.32
▸ MAOB P27338 1/20 0.32
▸ SLC6A2 P23975 1/20 0.31
▸ HRH2 P25021 1/20 0.31
▸ DRD3 P35462 1/20 0.31
▸ SLC6A3 Q01959 1/20 0.31
▸ ROCK2 O75116 2/20 0.31
▸ METAP2 P50579 1/20 0.31
▸ ACAT2 Q9BWD1 1/20 0.30
▸ APP P05067 1/20 0.30
▸ ATG4B Q9Y4P1 1/20 0.30
▸ ROCK1 Q13464 1/20 0.30
▸ LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17758053 0.90 MEN1 (0.36) MEN1KMT2ASSTR3KDM1AMAOA
SCHEMBL16410778 0.88 LMNA (0.38) LMNA
SCHEMBL16410841 0.88 KDM1A (0.32) KDM1AACAT2APPATG4BLMNA
SCHEMBL16410832 0.85 KDM4E (0.35) MEN1KMT2AROCK1
SCHEMBL16410840 0.82 ACAT2 (0.42) KMT2AMETAP2ACAT2APPLMNA
SCHEMBL16410799 0.80 LMNA (0.32) LMNA
SCHEMBL16410606 0.79 ACAT2 (0.40) KMT2AACAT2
SCHEMBL17757232 0.79 SSTR3 (0.38) KMT2ASSTR3KDM1AMAOAMAOB
SCHEMBL16410721 0.78 SIGMAR1 (0.33) MEN1KMT2ASSTR3LMNA
SCHEMBL17758049 0.78 ACAT2 (0.43) MEN1KMT2AMAOBACAT2APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015007730-A1 SPIROQUINOXALINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) 2015-01-22 — — WO disclosed
Send feedback